GWENDOLYN CHARLEE: Open Payments
NPI 1356049449 · RIO RANCHO, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 14 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $307 |
| Phathom Pharmaceuticals, Inc. | 1 | $119 |
| ABBVIE INC. | 1 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: IBSRELA, VOQUEZNA, CREON, ENTYVIO, XIFAXAN, TREMFYA.
Industry payments across NM — which companies pay providers there.
